Weight loss, glucose control, cardiometabolic improvement and Zepbound treatment of moderate-to-severe obstructive sleep apnea in adults with obesity.
Traducción automática para su comodidad. Para decisiones médicas,
confirme los detalles con nuestro equipo bilingüe.
FDA-approved products
Tirzepatide: evidence, status & safety
Tirzepatide is a peptide-based dual GIP and GLP-1 receptor agonist. FDA-approved products have product-specific indications including type 2 diabetes, chronic weight management and moderate-to-severe obstructive sleep apnea in adults with obesity.
What patients should know first
In SURMOUNT-1, mean weight change at 72 weeks was −15.0%, −19.5% and −20.9% at 5, 10 and 15 mg, compared with −3.1% with placebo. Participants did not have diabetes and all groups received lifestyle intervention.
Tirzepatide is not retatrutide. Approved tirzepatide does not establish the safety or efficacy of research-labeled or compounded products.
FDA-approved labeling added postmarketing intestinal obstruction and severe constipation, including fecal impaction. FDA also removed the suicidal-behavior warning after its class-wide review found no increased risk. Other boxed warnings, contraindications and precautions remain.
5 mg
−15.0%
Mean change at 72 weeks
10 mg
−19.5%
Mean change at 72 weeks
15 mg
−20.9%
Mean change at 72 weeks
Placebo
−3.1%
Mean change at 72 weeks
Interpretation
Do not confuse a molecule with a verified medication
The name of an active ingredient does not verify the product in a vial. FDA approval, when it exists, applies to a specific product and indication. A compounded version is not FDA-approved, and a research-labeled product is not approved for human use.
Clinical supervision should include diagnosis, contraindication and interaction review, realistic outcome discussion, a valid prescription, traceable sourcing and follow-up. It cannot make an anonymous or counterfeit product safe.
FDA-approved tirzepatide and an unknown vial are not the same
thing.
Product identity, formulation, manufacturing controls, dispensing source and labeling all matter. A familiar active ingredient name should never be treated as proof that an online or research-labeled product is legitimate.
Put tirzepatide in the right context
Evidence Before Treatment
Know the status.
Know the status.
Verify the source.
This guide is educational and cannot determine whether tirzepatide is appropriate for you. Individual treatment decisions require evaluation by an appropriately licensed clinician.